Rocket Pharmaceuticals, Inc.
RCKT
$3.60
-$0.04-1.10%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 16.16% | -19.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.17% | -16.00% | |||
| Operating Income | -10.17% | 16.00% | |||
| Income Before Tax | -11.89% | 15.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.89% | 15.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.89% | 15.49% | |||
| EBIT | -10.17% | 16.00% | |||
| EBITDA | -10.88% | 14.98% | |||
| EPS Basic | -11.54% | 15.65% | |||
| Normalized Basic EPS | -11.06% | 16.18% | |||
| EPS Diluted | -11.54% | 15.65% | |||
| Normalized Diluted EPS | -11.06% | 16.18% | |||
| Average Basic Shares Outstanding | 0.31% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.31% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||